{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T17:15:14Z","timestamp":1777396514290,"version":"3.51.4"},"reference-count":45,"publisher":"SAGE Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2023,10,10]]},"abstract":"<jats:p>Background: Tyrosine-protein kinase receptor Ret (RET), a proto-oncogene, is considered as an attractive drug target for cancer and neurodegenerative diseases, including Alzheimer\u2019s disease (AD). Objective: We aimed to identify potential inhibitors of RET kinase among natural compounds present in the ZINC database. Methods: A multistep structure-based virtual screening approach was used to identify potential RET kinase inhibitors based on their binding affinities, docking scores, and interactions with the biologically important residues of RET kinase. To further validate the potential of these compounds as therapeutic leads, molecular dynamics (MD) simulations for 100\u200ans were carried out and subsequently evaluated the stability, conformational changes, and interaction mechanism of RET in-complex with the elucidated compounds. Results: Two natural compounds, ZINC02092851 and ZINC02726682, demonstrated high affinity, specificity for the ATP-binding pocket of RET and drug-likeness properties. The MD simulation outputs indicated that the binding of both compounds stabilizes the RET structure and leads to fewer conformational changes. Conclusions: The findings suggest that ZINC02092851 and ZINC02726682 may be potential inhibitors for RET, offering valuable leads for drug development against RET-associated diseases. Our study provides a promising avenue for developing new therapeutic strategies against complex diseases, including AD. Identifying natural compounds with high affinity and specificity for RET provides a valuable starting point for developing novel drugs that could help combat these debilitating diseases.<\/jats:p>","DOI":"10.3233\/jad-230698","type":"journal-article","created":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T13:43:32Z","timestamp":1694526212000},"page":"1519-1533","source":"Crossref","is-referenced-by-count":5,"title":["Structure-Based Identification of Natural Compounds as Potential RET-Kinase Inhibitors for Therapeutic Targeting of Neurodegenerative Diseases"],"prefix":"10.1177","volume":"95","author":[{"given":"Gulam Mustafa","family":"Hasan","sequence":"first","affiliation":[{"name":"Department of Biochemistry College of Medicine Prince Sattam Bin Abdulaziz University, Al-Kharj, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anas","family":"Shamsi","sequence":"additional","affiliation":[{"name":"Centre of Medical and Bio-Allied Health Sciences Research Ajman University, Ajman, United Arab Emirates"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sukhwinder Singh","family":"Sohal","sequence":"additional","affiliation":[{"name":"Respiratory Translational Research Group Department of Laboratory Medicine School of Health Sciences College of Health and Medicine University of Tasmania, Launceston, Tasmania, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manzar","family":"Alam","sequence":"additional","affiliation":[{"name":"Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md. Imtaiyaz","family":"Hassan","sequence":"additional","affiliation":[{"name":"Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-230698_ref1","doi-asserted-by":"crossref","first-page":"14628","DOI":"10.1074\/jbc.M110.195461","article-title":"RET modulates cell adhesion via its cleavage by caspase in sympathetic neurons","volume":"286","author":"Cabrera","year":"2011","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-230698_ref2","doi-asserted-by":"crossref","first-page":"17292","DOI":"10.1074\/jbc.M110.168500","article-title":"Focal adhesion kinase (FAK) binds RET kinase via its FERM domain, priming a direct and reciprocal RET-FAK transactivation mechanism","volume":"286","author":"Plaza-Menacho","year":"2011","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-230698_ref3","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1016\/j.jpedsurg.2008.11.055","article-title":"Transcriptional regulation of RET by Nkx2-1, Phox2b, Sox10, and Pax3","volume":"44","author":"Leon","year":"2009","journal-title":"J Pediatr Surg"},{"key":"10.3233\/JAD-230698_ref4","doi-asserted-by":"crossref","first-page":"5448","DOI":"10.1210\/en.2004-0922","article-title":"Minireview: RET: Normal and abnormal functions","volume":"145","author":"Santoro","year":"2004","journal-title":"Endocrinology"},{"key":"10.3233\/JAD-230698_ref5","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1159\/000318502","article-title":"Functional role of the RET dependence receptor, GFRa co-receptors and ligands in the pituitary","volume":"38","author":"Garcia-Lavandeira","year":"2010","journal-title":"Front Horm Res"},{"key":"10.3233\/JAD-230698_ref6","doi-asserted-by":"crossref","first-page":"E342","DOI":"10.1210\/jc.2010-0771","article-title":"RET-mediated cell adhesion and migration require multiple integrin subunits","volume":"95","author":"Cockburn","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.3233\/JAD-230698_ref7","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1093\/hmg\/2.7.851","article-title":"Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC","volume":"2","author":"Donis-Keller","year":"1993","journal-title":"Hum Mol Genet"},{"key":"10.3233\/JAD-230698_ref8","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1159\/000472371","article-title":"Heterogeneity and low detection rate of RET mutations in Hirschsprung disease","volume":"2","author":"Yin","year":"1994","journal-title":"Eur J Hum Genet"},{"key":"10.3233\/JAD-230698_ref9","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/hmg\/3.2.237","article-title":"Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours","volume":"3","author":"Eng","year":"1994","journal-title":"Hum Mol Genet"},{"key":"10.3233\/JAD-230698_ref10","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1038\/nm.4392","article-title":"GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates","volume":"23","author":"Mullican","year":"2017","journal-title":"Nat Med"},{"key":"10.3233\/JAD-230698_ref11","doi-asserted-by":"crossref","first-page":"5886","DOI":"10.1016\/j.bmcl.2007.07.104","article-title":"The discovery of substituted 4-(3-hydroxyanilino)-quinolines as potent RET kinase inhibitors","volume":"17","author":"Graham Robinett","year":"2007","journal-title":"Bioorg Med Chem Lett"},{"key":"10.3233\/JAD-230698_ref12","doi-asserted-by":"crossref","first-page":"7108","DOI":"10.3390\/ijms21197108","article-title":"RET receptor tyrosine kinase: Role in neurodegeneration, obesity, and cancer","volume":"21","author":"Mahato","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.3233\/JAD-230698_ref13","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/j.annonc.2020.09.015","article-title":"Mechanisms of resistance to selective RET tyrosine kinase inhibitors in RET fusion-positive non-small-cell lung cancer","volume":"31","author":"Lin","year":"2020","journal-title":"Ann Oncol"},{"key":"10.3233\/JAD-230698_ref14","first-page":"472","article-title":"RET kinase alterations in targeted cancer therapy","volume":"3","author":"Liu","year":"2020","journal-title":"Cancer Drug Resist"},{"key":"10.3233\/JAD-230698_ref15","doi-asserted-by":"crossref","first-page":"162","DOI":"10.2174\/092986711794088308","article-title":"Development of RET kinase inhibitors for targeted cancer therapy","volume":"18","author":"Mologni","year":"2011","journal-title":"Curr Med Chem"},{"key":"10.3233\/JAD-230698_ref16","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.annonc.2020.10.599","article-title":"Structural basis of acquired resistance to selpercatinib and pralsetinib mediated by non-gatekeeper RET mutations","volume":"32","author":"Subbiah","year":"2021","journal-title":"Ann Oncol"},{"key":"10.3233\/JAD-230698_ref17","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.bmc.2010.01.011","article-title":"Synthesis, structure\u2013activity relationship and crystallographic studies of 3-substituted indolin-2-one RET inhibitors","volume":"18","author":"Mologni","year":"2010","journal-title":"Bioorg Med Chem"},{"key":"10.3233\/JAD-230698_ref18","doi-asserted-by":"crossref","first-page":"7872","DOI":"10.1039\/D1RA09339H","article-title":"Bioactive phytoconstituents as potent inhibitors of casein kinase-2: Dual implications in cancer and COVID-19 therapeutics","volume":"12","author":"Anjum","year":"2022","journal-title":"RSC Adv"},{"key":"10.3233\/JAD-230698_ref19","doi-asserted-by":"crossref","first-page":"504","DOI":"10.22270\/jddt.v8i5.1894","article-title":"Computer aided drug design: An overview","volume":"8","author":"Surabhi","year":"2018","journal-title":"J Drug Deliv Ther"},{"key":"10.3233\/JAD-230698_ref20","doi-asserted-by":"crossref","first-page":"823","DOI":"10.3390\/molecules25040823","article-title":"Virtual screening approach to identify high-affinity inhibitors of serum and glucocorticoid-regulated kinase 1 among bioactive natural products: Combined molecular docking and simulation studies","volume":"25","author":"Mohammad","year":"2020","journal-title":"Molecules"},{"key":"10.3233\/JAD-230698_ref21","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.drudis.2013.01.007","article-title":"The holistic integration of virtual screening in drug discovery","volume":"18","author":"Tanrikulu","year":"2013","journal-title":"Drug Discov Today"},{"key":"10.3233\/JAD-230698_ref22","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1016\/j.sjbs.2021.01.040","article-title":"Identification of natural compounds as potent inhibitors of SARS-CoV-2 main protease using combined docking and molecular dynamics simulations","volume":"28","author":"Jairajpuri","year":"2021","journal-title":"Saudi J Biol Sci"},{"key":"10.3233\/JAD-230698_ref23","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.3390\/pharmaceutics13122157","article-title":"Identification of phytoconstituents as potent inhibitors of casein kinase-1 alpha using virtual screening and molecular dynamics simulations","volume":"13","author":"Shafie","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.3233\/JAD-230698_ref24","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1021\/ci049714+","article-title":"ZINC\u2013a free database of commercially available compounds for virtual screening","volume":"45","author":"Irwin","year":"2005","journal-title":"J Chem Info Mod"},{"key":"10.3233\/JAD-230698_ref25","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","article-title":"Lead-and drug-like compounds: The rule-of-five revolution","volume":"1","author":"Lipinski","year":"2004","journal-title":"Drug Discov Today Technol"},{"key":"10.3233\/JAD-230698_ref26","first-page":"92037","article-title":"Using AutoDock 4 and AutoDock vina with AutoDockTools: A tutorial","volume":"10550","author":"Huey","year":"2012","journal-title":"The Scripps Research Institute Molecular Graphics Laboratory"},{"key":"10.3233\/JAD-230698_ref27","first-page":"82","article-title":"Pymol: An open-source molecular graphics tool","volume":"40","author":"DeLano","year":"2002","journal-title":"CCP4 Newsl. Protein Crystallogr"},{"key":"10.3233\/JAD-230698_ref28","doi-asserted-by":"crossref","unstructured":"Eswar N , Webb B , Marti-Renom MA , Madhusudhan M , Eramian D , Shen My , Pieper U , Sali A (2006) Comparative protein structure modeling using Modeller. Curr Protoc Bioinformatics Chapter 5, Unit-5.6.","DOI":"10.1002\/0471250953.bi0506s15"},{"key":"10.3233\/JAD-230698_ref29","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1002\/elps.1150181505","article-title":"SWISS-MODEL and the Swiss-Pdb Viewer: An environment for comparative protein modeling","volume":"18","author":"Guex","year":"1997","journal-title":"Electrophoresis"},{"key":"10.3233\/JAD-230698_ref30","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1002\/pro.5560020916","article-title":"Verification of protein structures: Patterns of nonbonded atomic interactions","volume":"2","author":"Colovos","year":"1993","journal-title":"Protein Sci"},{"key":"10.3233\/JAD-230698_ref31","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1126\/science.1853201","article-title":"A method to identify protein sequences that fold into a known three-dimensional structure","volume":"253","author":"Bowie","year":"1991","journal-title":"Science"},{"key":"10.3233\/JAD-230698_ref32","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1006\/jmbi.1996.0628","article-title":"Deviations from standard atomic volumes as a quality measure for protein crystal structures","volume":"264","author":"Pontius","year":"1996","journal-title":"J Mol Biol"},{"key":"10.3233\/JAD-230698_ref33","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/381272a0","article-title":"Errors in protein structures","volume":"381","author":"Hooft","year":"1996","journal-title":"Nature"},{"key":"10.3233\/JAD-230698_ref34","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1107\/S0021889892009944","article-title":"PROCHECK: A program to check the stereochemical quality of protein structures","volume":"26","author":"Laskowski","year":"1993","journal-title":"J Appl Crystallogr"},{"key":"10.3233\/JAD-230698_ref35","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1515\/bmc.2010.022","article-title":"A fresh look at the Ramachandran plot and the occurrence of standard structures in proteins","volume":"1","author":"Hollingsworth","year":"2010","journal-title":"BioMol Concepts"},{"key":"10.3233\/JAD-230698_ref36","doi-asserted-by":"crossref","first-page":"bbaa279","DOI":"10.1093\/bib\/bbaa279","article-title":"InstaDock: A single-click graphical user interface for molecular docking-based virtual high-throughput screening","volume":"22","author":"Mohammad","year":"2021","journal-title":"Brief Bioinform"},{"key":"10.3233\/JAD-230698_ref37","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1021\/acs.jcim.5b00559","article-title":"ZINC 15\u2013Ligand discovery for everyone","volume":"55","author":"Sterling","year":"2015","journal-title":"J Chem Inf Model"},{"key":"10.3233\/JAD-230698_ref38","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci Rep"},{"key":"10.3233\/JAD-230698_ref39","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","article-title":"pkCSM: Predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures","volume":"58","author":"Pires","year":"2015","journal-title":"J Med Chem"},{"key":"10.3233\/JAD-230698_ref40","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1038\/s41598-017-02365-0","article-title":"CarcinoPred-EL: Novel models for predicting the carcinogenicity of chemicals using molecular fingerprints and ensemble learning methods","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci Rep"},{"key":"10.3233\/JAD-230698_ref41","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/jcc.20291","article-title":"GROMACS: Fast, flexible, and free","volume":"26","author":"Van Der Spoel","year":"2005","journal-title":"J Comput Chem"},{"key":"10.3233\/JAD-230698_ref42","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/BF00355047","article-title":"PRODRG, a program for generating molecular topologies and unique molecular descriptors from coordinates of small molecules","volume":"10","author":"VanAalten","year":"1996","journal-title":"J Comp-Aid Mol Des"},{"key":"10.3233\/JAD-230698_ref43","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1124\/mi.3.2.90","article-title":"Blood-brain barrier drug targeting: The future of brain drug development","volume":"3","author":"Pardridge","year":"2003","journal-title":"Mol Interv"},{"key":"10.3233\/JAD-230698_ref44","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s10593-014-1496-1","article-title":"Prediction of the biological activity spectra of organic compounds using the PASS online web resource","volume":"50","author":"Filimonov","year":"2014","journal-title":"Chem Heterocycl Compd (N Y)"},{"key":"10.3233\/JAD-230698_ref45","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.3390\/molecules27103060","article-title":"Bioactive phytoconstituents as potent inhibitors of tyrosine-protein kinase yes (YES1): Implications in anticancer therapeutics","volume":"27","author":"Yang","year":"2022","journal-title":"Molecules"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-230698","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:08:33Z","timestamp":1777370913000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-230698"}},"subtitle":[],"editor":[{"given":"Rekha","family":"Khandia","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2023,10,10]]},"references-count":45,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.3233\/jad-230698","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,10]]}}}